Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Inflammatory Bowel Diseases

Free Subscription 13.04.2026 2 Aliment Pharmacol Ther 1 Clin Gastroenterol Hepatol 1 Dig Dis Sci 2 Gastroenterol Hepatol 3 Gut 1 Hum Pathol 2 Inflamm Bowel Dis 1 J Crohns Colitis 1 J Gastroenterol 1 JAMA

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. KUMAR A, Patil AN, Sharma V
   Letter: Steroid Tapering in Ulcerative Colitis-The Importance of Disease Severity and Maintenance Therapy. Authors' Reply.
   Aliment Pharmacol Ther. 2026 Apr 8. doi: 10.1111/apt.70661.
   PubMed        
   
   
2. O'CONNOR R, Karunadasa H, Vasudevan A
   Letter: Steroid Tapering in Ulcerative Colitis: The Importance of Disease Severity and Maintenance Therapy.
   Aliment Pharmacol Ther. 2026 Apr 5. doi: 10.1111/apt.70642.
   PubMed        
   
   

   
   Clin Gastroenterol Hepatol

3. HANAUER SB, Colombel JF
   Reply to: Subcutaneous Infliximab and Assumptions of Response in Ileal Crohn's Disease: Does Route of Administration Matter?
   Clin Gastroenterol Hepatol. 2026 Apr 2:S1542-3565(26)00237.
   PubMed        
   
   

   
   Dig Dis Sci

4. NAPOLITANO D, Bassola B, Lusignani M, Cilluffo S, et al
   The Role of Nurse-Patient Mutuality on Self-Care Behaviors in Adults Living with Inflammatory Bowel Disease: A Multicenter Cross-Sectional Study.
   Dig Dis Sci. 2026 Apr 4. doi: 10.1007/s10620-026-09883.
   PubMed         Abstract available
   
   

   
   Gastroenterol Hepatol

5. VILLAR GF, Garagoli F, Elhelou SM, Masson W, et al
   Subclinical atherosclerosis in inflammatory bowel disease: Prevalence, vascular distribution and implications for cardiovascular risk stratification.
   Gastroenterol Hepatol. 2026 Apr 2:502755. doi: 10.1016/j.gastrohep.2026.502755.
   PubMed         Abstract available
   
   
6. TUMA ISM, Cambi MPC, de Oliveira Dominski SF, Ignacio P, et al
   Food-related quality of life in inflammatory bowel disease: validity and reliability of the Brazilian version of the FR-QoL-29-Portuguese-Brazil.
   Gastroenterol Hepatol. 2026 Mar 31:502754. doi: 10.1016/j.gastrohep.2026.502754.
   PubMed         Abstract available
   
   

   
   Gut

7. ZHANG J, Hu J, Tang X, Ruan Y, et al
   Quantifying artificial sweeteners and emulsifiers in Crohn's disease and its relationship with disease activity: the ENIGMA study - a novel and targeted approach.
   Gut. 2026 Apr 8:gutjnl-2024-333999. doi: 10.1136/gutjnl-2024-333999.
   PubMed         Abstract available
   
   
8. BIRDA CL, Jena A, Torres J, Ng SC, et al
   Road to IBD prevention in the Global South: a conceptual framework modelling from non-communicable diseases.
   Gut. 2026;75:1055-1066.
   PubMed         Abstract available
   
   
9. TAN H, Huang L, Wang J, Huang H, et al
   Parasutterella excrementihominis exacerbates experimental colitis and colitis-associated colorectal cancer via pathogenic NETosis activation.
   Gut. 2025 Dec 25:gutjnl-2025-335887. doi: 10.1136/gutjnl-2025-335887.
   PubMed         Abstract available
   
   

   
   Hum Pathol

10. ERTEKIN R, Hu J, Hosseini M, Patel C, et al
    Is it justified to order an upfront cytomegalovirus immunohistochemical stain in patients with severe inflammatory bowel disease and ulceration?
    Hum Pathol. 2026;173:106113.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

11. VERLEYE LMM, Pierik MJ, de Vries AC, van Schaik FDM, et al
    Prospective real-world experience with risankizumab in difficult-to-treat Crohn's disease: results from the Dutch Initiative on Crohn and Colitis Registry.
    Inflamm Bowel Dis. 2026 Apr 4:izag045. doi: 10.1093.
    PubMed         Abstract available
    
    
12. WONG ECL, Marshall JK, Ma C, Jairath V, et al
    Efficacy and safety of ulcerative colitis therapies do not differ by age: A post hoc analysis of randomized controlled trials.
    Inflamm Bowel Dis. 2026 Apr 4:izag054. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

13. EL OUALI S, Baker ME, Lu C, Medellin A, et al
    Ustekinumab for ileal stricturing Crohn's disease-an international multicenter retrospective cohort study.
    J Crohns Colitis. 2026;20:jjag038.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

14. LI X, Pan S, Li Q, Yu B, et al
    Volatomics-based biomarkers for non-invasive diagnosis and monitoring of inflammatory bowel disease.
    J Gastroenterol. 2026 Apr 9. doi: 10.1007/s00535-026-02409.
    PubMed         Abstract available
    
    

    
    JAMA

15. CHODEN T, Levine E, Davis AM
    Management of Crohn Disease in Adults.
    JAMA. 2026 Apr 8. doi: 10.1001/jama.2026.1239.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum